Atlas Trials

Effect of Linagliptin on Insulin Sensitivity and Pancreatic Beta Cell Function in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT02097342 · UNKNOWN

Trial details

NCT number
NCT02097342
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes MellitusInsulin Sensitivity/Resistance
Start date
2013-12-01
Primary completion
2014-11-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.